05:48 AM EDT, 08/29/2025 (MT Newswires) -- Eli Lilly ( LLY ) is partnering with China's JD Health International internet healthcare platform to sell its obesity and diabetes drugs to Chinese consumers online, Bloomberg reported Friday, citing Eli Lilly's ( LLY ) official WeChat account.

The move follows similar moves by Eli Lilly ( LLY ) competitors to sell weight-loss and diabetes drugs directly to patients, the report said.

The partnership will streamline consumer access to Eli Lilly ( LLY ) drugs, such as Mounjaro, through JD Health's platform, which includes online consultations and prescriptions as well as delivery, the report said.

Eli Lilly ( LLY ) did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)